Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 7/20 | 0.72 |
| ▸ | MMP2 | P08253 | 7/20 | 0.72 |
| ▸ | MMP9 | P14780 | 7/20 | 0.72 |
| ▸ | BCHE | P06276 | 1/20 | 0.59 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.59 |
| ▸ | ACHE | P22303 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | MAPT | P10636 | 3/20 | 0.58 |
| ▸ | NPC1 | O15118 | 3/20 | 0.58 |
| ▸ | RAB9A | P51151 | 3/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.58 |
| ▸ | TP53 | P04637 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6756799 | 0.87 | MMP1 (0.66) | MMP1MMP2MMP9SMN1; SMN2ALDH1A1 | |
| SCHEMBL8061581 | 0.86 | MMP1 (0.75) | MMP1MMP2MMP9BCHETRPV1 | |
| SCHEMBL8061578 | 0.86 | MMP1 (0.75) | MMP1MMP2MMP9BCHETRPV1 | |
| SCHEMBL6759894 | 0.85 | MMP1 (0.70) | MMP1MMP2MMP9SMN1; SMN2MAPT | |
| SCHEMBL247434 | 0.84 | MMP1 (1.00) | MMP1MMP2MMP9TRPV1SMN1; SMN2 | |
| SCHEMBL247433 | 0.84 | MMP1 (1.00) | MMP1MMP2MMP9TRPV1SMN1; SMN2 | |
| SCHEMBL247432 | 0.84 | MMP1 (1.00) | MMP1MMP2MMP9TRPV1SMN1; SMN2 | |
| SCHEMBL30080242 | 0.84 | MMP1 (1.00) | MMP1MMP2MMP9TRPV1SMN1; SMN2 | |
| SCHEMBL6756820 | 0.83 | MMP1 (0.70) | MMP1MMP2MMP9TRPV1SMN1; SMN2 | |
| SCHEMBL6754294 | 0.81 | MMP1 (0.64) | MMP1MMP2MMP9SMN1; SMN2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040087798-A1 | Novel amide compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-05-06 | — | — | US | disclosed |
| EP-1264820-A1 | NOVEL AMIDE COMPOUNDS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-12-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040087798-A1 | Novel amide compounds | H1-2, H1-0, H1-3 | MMP1 3985/4885MMP2 4187/4885MMP9 4335/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.